| Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1 A Luttun, M Tjwa, L Moons, Y Wu, A Angelillo-Scherrer, F Liao, JA Nagy, ... Nature medicine 8 (8), 831-840, 2002 | 1485 | 2002 |
| Vascular permeability factor (VPF, VEGF) in tumor biology DR Senger, L Van De Water, LF Brown, JA Nagy, KT Yeo, TK Yeo, ... Cancer and Metastasis Reviews 12 (3), 303-324, 1993 | 1314 | 1993 |
| A human leukocyte differentiation antigen family with distinct alpha-subunits and a common beta-subunit: the lymphocyte function-associated antigen (LFA-1), the C3bi complement … F Sanchez-Madrid, JA Nagy, E Robbins, P Simon, TA Springer The Journal of experimental medicine 158 (6), 1785-1803, 1983 | 1093 | 1983 |
| Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules HF Dvorak, JA Nagy, JT Dvorak, AM Dvorak The American journal of pathology 133 (1), 95, 1988 | 1021 | 1988 |
| Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis HF Dvorak, JA Nagy, D Feng, LF Brown, AM Dvorak Vascular growth factors and angiogenesis, 97-132, 1999 | 972 | 1999 |
| Why are tumour blood vessels abnormal and why is it important to know? JA Nagy, SH Chang, AM Dvorak, HF Dvorak British journal of cancer 100 (6), 865-869, 2009 | 828 | 2009 |
| Vascular permeability, vascular hyperpermeability and angiogenesis JA Nagy, L Benjamin, H Zeng, AM Dvorak, HF Dvorak Angiogenesis 11 (2), 109-119, 2008 | 807 | 2008 |
| The functional significance, distribution, and structure of LFA-1, LFA-2, and LFA-3: cell surface antigens associated with CTL-target interactions. AM Krensky, F Sanchez-Madrid, E Robbins, JA Nagy, TA Springer, ... Journal of immunology (Baltimore, Md.: 1950) 131 (2), 611-616, 1983 | 781 | 1983 |
| Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis JA Nagy, E Vasile, D Feng, C Sundberg, LF Brown, MJ Detmar, JA Lawitts, ... The Journal of experimental medicine 196 (11), 1497-1506, 2002 | 762 | 2002 |
| Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine LF Brown, M Detmar, K Claffey, JA Nagy, D Feng, AM Dvorak, HF Dvorak Regulation of angiogenesis, 233-269, 1997 | 690 | 1997 |
| Heterogeneity of the tumor vasculature JA Nagy, SH Chang, SC Shih, AM Dvorak, HF Dvorak Seminars in thrombosis and hemostasis 36 (03), 321-331, 2010 | 646 | 2010 |
| Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. HF Dvorak, TM Sioussat, LF Brown, B Berse, JA Nagy, A Sotrel, ... The Journal of experimental medicine 174 (5), 1275-1278, 1991 | 644 | 1991 |
| VEGF-A and the induction of pathological angiogenesis JA Nagy, AM Dvorak, HF Dvorak Annu. Rev. Pathol. Mech. Dis. 2 (1), 251-275, 2007 | 627 | 2007 |
| Antiangiogenic properties of gold nanoparticles P Mukherjee, R Bhattacharya, P Wang, L Wang, S Basu, JA Nagy, A Atala, ... Clinical cancer research 11 (9), 3530-3534, 2005 | 623 | 2005 |
| Neutrophils emigrate from venules by a transendothelial cell pathway in response to FMLP D Feng, JA Nagy, K Pyne, HF Dvorak, AM Dvorak The Journal of experimental medicine 187 (6), 903-915, 1998 | 580 | 1998 |
| Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor A Pettersson, JA Nagy, LF Brown, C Sundberg, E Morgan, S Jungles, ... Laboratory investigation 80 (1), 99-115, 2000 | 577 | 2000 |
| Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition JA Nagy, LF Brown, DR Senger, N Lanir, L Van De Water, AM Dvorak, ... Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 948 (3), 305-326, 1989 | 548 | 1989 |
| Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin TL Phung, K Ziv, D Dabydeen, G Eyiah-Mensah, M Riveros, C Perruzzi, ... Cancer cell 10 (2), 159-170, 2006 | 545 | 2006 |
| The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor S Basu, JA Nagy, S Pal, E Vasile, IA Eckelhoefer, V Susan Bliss, ... Nature medicine 7 (5), 569-574, 2001 | 513 | 2001 |
| Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts. SI Harada, JA Nagy, KA Sullivan, KA Thomas, N Endo, GA Rodan, ... The Journal of clinical investigation 93 (6), 2490-2496, 1994 | 498 | 1994 |
Kiang-Teck J. Yeo, PhDProfessor of Pathology, University of ChicagoVerified email at bsd.uchicago.edu
